Pragmatic trial to assess the possibility of enhancing the effectiveness of tinnitus retraining therapy (TRT) by concomitant treatment with Ginkgo biloba extract EGb 761 in patients with chronic tinnitus

Trial Profile

Pragmatic trial to assess the possibility of enhancing the effectiveness of tinnitus retraining therapy (TRT) by concomitant treatment with Ginkgo biloba extract EGb 761 in patients with chronic tinnitus

Discontinued
Phase of Trial: Phase II

Latest Information Update: 14 Jun 2017

At a glance

  • Drugs EGb 761 (Primary)
  • Indications Tinnitus
  • Focus Therapeutic Use
  • Sponsors Dr. Willmar Schwabe Pharmaceuticals
  • Most Recent Events

    • 09 Jun 2017 Status changed from completed to discontinued.
    • 01 Jul 2016 Status changed from recruiting to completed.
    • 10 Jun 2014 Status changed from not yet recruiting to recruiting, according to ISRCTN: Current Controlled Trials record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top